Aug 7 (Reuters) - Swiss pharmaceutical company Roche
is considering divesting cancer data specialist Flatiron
Health, the Financial Times reported on Wednesday, citing people
familiar with the matter.
Roche had paid $1.9 billion for New-York based Flatiron
Health in 2018.
(Reporting by Akanksha Khushi in Bengaluru; Editing by Varun H
K)